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Different Viola species are known for their traditional use as analgesic, antitussive, febri-
fuge, hipnotic, analgesic and anti-inflammatory medicinal agents. Additionally, they are
considered edible flowers in certain cultures. Thus, the aim of this work was to charac-
terize the phenolic composition and to assess the neuroprotective properties of Viola cor-
nuta and Viola x wittrockiana using in vitro and in vivo methodologies with Caenorhabditis
elegans as model. The identification of the phenolic compounds was carried out with a LC-
DAD-ESI/MSn. The antioxidant activity of the extracts was determined in vitro using Folin-
Ciocalteu, DPPH and FRAP assays and in vivo with a juglone-induced oxidative stress in C.
elegans. The neuroprotective properties were evaluated measuring the ability to inhibit CNS
enzymes (MAO A, AChE), and the capability to avoid paralyzing the C. elegans CL4176, an
Alzheimer disease model. The phenolic content was higher in V. x wittrockiana, being
quercetin-3-O-(6-O-rhamnosylglucoside)-7-O-rhamnoside the predominant compound in
the extract, which also exhibited a stronger antioxidant capacity in vitro and a higher
response to lethal oxidative stress on C. elegans than V. cornuta. Only V. x wittrockiana
showed inhibitory effect on CNS enzymes, such as acetylcholinesterase and monoamine
oxidase A, but both had protective effect against the paralysis of C. elegans. These findings
suggest that the studied V. cornuta and V. x wittrockiana could be interesting candidates for
age related neurodegenerative disorder associated with oxidative stress.
Copyright © 2019, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).5.
. Ferreira), cgomez@usj.e
inistration, Taiwan. Publis
/licenses/by-nc-nd/4.0/).s (C.G. Rincon).
hed by Elsevier Taiwan LLC. This is an open access article under the CC
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 7 ( 2 0 1 9 ) 8 4 9e8 5 98501. Introduction
Disorders of the Central Nervous System (CNS) such as Alz-
heimer's and Parkinson's disease are among the most preva-
lent pathologies in relation with oxidative stress and ageing.
Despite the importance of medicines to improve the quality of
life of these patients, most drugs just act as symptomatic
treatments and the development of new drugs to treat or
prevent them is limited [1].
In certain systems of traditional medicine, the use of
various species of genusViolahas been reported as CNS agents
[2,3], this fact is a good starting point to explore the potential
of understudied species such as V cornuta L. (horned violet)
and Viola x wittrockiana Gams (pansy) for neuroprotective ac-
tivities, and related bioactivities with neurodegeneration such
as antioxidant and anti-ageing properties. Previous studies
about the chemical composition and antioxidant activity of V.
xwittrockiana, have already been performed [4e6]. However, to
the best of our knowledge, this is the first report about the
phenolic composition and properties of V. cornuta.
New methods are currently being implemented and used
for drug testing, particularly in the field of natural products.
The use ofmammals in experimentation is not only expensive
and laborious, but also associated to ethical limitations. For
these reasons, other models for screening and preliminary
studies must be used. C. elegans, is, indeed, a good model
because these organisms are small, easy handling and inex-
pensive. Moreover, signalling pathways and physiological
processes relevant for humans are conserved in this species,
and 60e80% of the human genes have homologues in C. ele-
gans [7]. Additionally, the easy genetic manipulation of this
nematode allows the existence of a wide range of mutant
strains and the possibility of developing specific ones.
Therefore, C. elegans is a powerful tool to test new bioactives,
allowing researchers the chance to study their biological ac-
tivity, and identifying primary or secondary targets, among
other possibilities [7].
Thus, the goal of this research is the characterization of
phenolic compounds and the assessment of antioxidant and
neuroprotective properties of V. cornuta and V. x wittrockiana
extracts, using both in vitro and in vivo assays.2. Material and methods
2.1. Standards and reagents
Acetonitrile (99.9%) was of HPLC grade from Fisher Scientific
(Lisbon, Portugal). Phenolic compound standards (apigenin-6-
C-glucoside, quercetin-3-O-glucoside, quercetin-3-O-rutino-
side, peonidin-3-O-glucoside) were from Extrasynthese
(Genay, France). Formic acid, DPPH· (2,2-diphenyl-1-
picrylhydrazyl), TPTZ (2,4,6-tris(2-pyridyl)-s-triazine), ATCI
(acetylthiocholine iodide), acetylcholinesterase (AChE),
monoamine oxidase A (MAO A), clorgiline, triseHCl and py-
rogallol were purchased from SigmaeAldrich (St. Louis, MO,
USA). DNTB (5,50-dithiobis (2-nitrobenzoic acid)) and juglone
(5-hydroxy-1,4-naphthoquinone) were from Alfa Aesar (Ward
Hill, MA, USA), Folin-Ciocalteu reagent was purchased fromChem-lab (Zeldelgem, Belgium).Waterwas treated in aMilli-Q
water purification system (TGI Pure Water Systems, Green-
ville, SC, USA).
2.2. Plant material and preparation of extracts
Cultivated fresh flowers ofV. cornuta andV. xwittrockianawere
supplied and botanically identified by Dr Laura Carrera from
Innoflower S.L. A voucher specimen was deposited in the
herbarium of Universidad San Jorge with numbers 003e2014
(V. cornuta) and 004e2014 (V. xwittrockiana). Ethanolic extracts
of flowers were obtained by percolation with a Soxhlet appa-
ratus for 4 h. Solvent was removed from the extract with a
rotary flash evaporator Buchi and the resulting extracts were
preserved at 20 C in order to avoid degradation until its use.
2.3. Analysis of phenolic compounds
The phenolic compound profile (non-anthocyanin com-
pounds and anthocyanin compounds) was determined
through an LC-DAD-ESI/MSn system using a Dionex Ultimate
3000 UPLC (Thermo Scientific, San Jose, CA, USA).
Non-anthocyanin compounds: These compounds were sepa-
rated and identified as previously described by Bessada et al.
[8]. The obtained extracts were re-dissolved at a concentration
of 10 mg/mL with ethanol. A double online detection was
performed using a DAD (280, 330 and 370 nm as preferred
wavelengths) and amass spectrometer (MS). TheMSdetection
was performed in negative mode, using a Linear Ion Trap LTQ
XL mass spectrometer (Thermo Finnigan, San Jose, CA, USA)
equipped with an ESI source.
Anthocyanin compounds: These compounds were separated
and identified as previously described by Gonc¸alves et al. [9].
The obtained extracts were re-dissolved at a concentration of
10 mg/mL with the acidified ethanol (0.05% TFA). For the
double online detection, a 520 nm wavelength was used as
preferred for the DAD and in aMS equipment described above,
working in positive mode.
The identification of the phenolic compounds (non-
anthocyanin and anthocyanin) was performed based on their
chromatographic behaviour, and UVevis and mass spectra by
comparison with standard compounds, when available, and
data reported in the literature giving a tentative identification.
Data acquisition was carried out with Xcalibur® data system
(Thermo Finnigan, San Jose, CA, USA). For quantitative anal-
ysis, a calibration curve for each available phenolic standard
was constructed based on the UVevis signal: apigenin-6-C-
glucoside (y ¼ 107025x þ 61,531, R2 ¼ 0.9989), quercetin-3-O-
glucoside (y ¼ 34843x e 160,173, R2 ¼ 0.9998), and peonidin-3-
O-glucoside (y ¼ 166905x e 442,698, R2 ¼ 0.9993). For the
identified phenolic compounds for which a commercial
standard was not available, the quantification was performed
through the calibration curve of the most similar compound.
Results were expressed as mg/g of extract.
2.4. In vitro cell-free antioxidant activity assays
2.4.1. Determination of Total Phenolic Content (TPC)
Total polyphenol content of flower extracts was measured
using a modified Folin-Ciocalteu method in a 96 well-
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mixed with 201 mL of Folin-Ciocalteu reagent in a well. After
5 min, 90 mL of 15% sodium carbonate were added and the
plate was incubated at room temperature in the darkness for
40 min. The absorbance was read at 750 nm and pyrogallol
was used as standard. Results were expressed as mg of py-
rogallol equivalent per g of extract (mg PE/g extract).
2.4.2. DPPH· radical scavenging activity assay
Free radical scavenging activity of the extracts was evaluated
with the DPPH· assay following themethod described by Lopez
et al. [11]. Flower extracts were serially diluted in ethanol
(2.5e250 mg/mL) and 150 mL of these dilutions or ethanol were
mixed with 150 mL of DPPH· (0.4 mg/mL, ethanol) in a plate.
After 30 min in the dark at room temperature, the absorbance
wasmeasured at 517 nm. DPPH· radical-scavenging activity, %
RSA, was calculated as:
RSA (%) ¼ [(ADPPHAS)/ADPPH]  100 (1)
where AS is the absorbance of solution containing the sample
and ADPPH is the absorbance of the DPPH
· ethanol blank
solution.
2.4.3. Ferric reducing antioxidant power assay (FRAP)
This assay was performed according to Fernandez-Moriano
et al. with minor modifications [12]. The FRAP reagent was
prepared daily and contained 2.5 mL of a TPTZ solution
(10mmol/L in 40mmol/L HCl), 2.5mL of FeCl3$6H2O (20mmol/
L) and 25mL of 0.3 mol/L sodium acetate buffer (pH 3.6). Then,
900 mL of FRAP reagent (warmed at 37 C) wasmixedwith 90 mL
of distilled water and 30 mL of flower extract (1 mg/mL in
methanol) or methanol as reagent blank. Absorbance was
measured after incubation at 37 C for 10min at wavelength of
595 nm. The antioxidant capacity of the extracts was esti-
mated by interpolating absorbance on a calibration curve of
FeSO4$7H2O and expressed as mmol Fe
þ2 per g of extract (mmol
Feþ2/g extract).
2.5. Neuroprotective potential
2.5.1. Acetylcholinesterase enzyme inhibitory activity
Inhibition of acetylcholinesterase enzyme (AChE) by the ex-
tracts was determined following the Ellmanmethod described
by Rhee et al. [13]. Briefly, 25 mL of ATCI (15 mM), 125 mL DNTB
(3 mM in 50 mmol/L TriseHCl buffer, pH ¼ 8.3), 50 mL of
TriseHCl buffer, 25 mL of extracts sample (0.125e2 mg/mL in
ethanol) or ethanol (control reaction) and 25 mL of AchE (0.22
U/mL) were mixed in each well of a microtiter plate. The
absorbance was measured 5 times at 405 nm every 12 s. Per-
centage of inhibition was calculated as:
Inhibition % ¼ [1/(VSVC)]  100 (2)
where VS is the reaction rate of the extract sample and VC is
the rate of control.
2.5.2. Monoamine oxidase A enzyme inhibitory activity
Monoamine oxidase A (MAO A) inhibitory activity was
measured by the peroxidase-linked assay described byStafford et al. [14]. Each test well contained 50 mL of flower
extract (0.002e0.250 mg/mL) or solvent, 50 mL of chromogenic
solution (0.8 mM vanillic acid, 417 mM 4-aminoantipyrine and
4 U/mL horseradish peroxidase), 100 mL of 2.5 mM tyramine
and 50 mL of 8 U/mLMAO-A. All components were dissolved in
potassium phosphate buffer (0.2 M, pH 7.6). Absorbance was
measured at 490 mn every 5 min over a period of 30 min.
Percentage of enzymatic inhibition was calculated using
equation 2.
2.6. In vivo biological activity - C. elegans assays
2.6.1. Worm strain, maintenance and treatment
N2 (wild type), CL4176 smg-1(cc546); dvls27, and SS104 glp-4
(bn2) C. elegans strains were used in this study and obtained
from Caenorhabditis Genetics Center (CGC, USA) USAWorms.
They were maintained on nematode growth medium (NGM)
agar plates seeded with a lawn of E. coli OP50 (CGC, USA), ac-
cording to standardizedmethods. N2 was propagated at 20 C,
while transgenic CL4176 and SS104 were maintained at 16 C.
For the assay, the plates were prepared from a stock solu-
tion of extracts in water. The solutions were added directly to
the agar during preparation of plates to the final indicated
concentration.
2.6.2. Oxidative stress resistance assay
The effect of the extracts on the response of wild type C. ele-
gans to a lethal oxidative stress was performed following
Surco-Laos et al. method with some modifications [15]. The
synchronized population were prepared by bleaching adults
and incubated in M9 buffer until the eggs hatched. L1 larvae
were incubated on NGM plates containing E. coli OP50 and
different concentrations of flower extract (0, 50, 100, 250 mg/
mL). Afterwards, adult worms were subjected to lethal
oxidative-stress by means of juglone (150 mM) in a microtiter
plate. After 24 h of incubation at 20 C, survival was measured
by a touch-provoked movement. Worms that reacted to the
mechanical stimulus were scored as alive, whereas non-
responding worms were considered dead. Results were
expressed as a percentage of survival rate and calculated as:
% Survival rate ¼ (Number of worms alive  100)/Total num-
ber of worms (3)
About 120 individuals per study group were evaluated in
each assay.
2.6.3. Lifespan assay
Survival analysis was performed as described by Virk et al.
with minor modifications [16]. Longevity of temperature-
sensitive sterile C. elegans SS104 exposed to 4 different con-
centrations of flowers extracts were measured and compared
to controls. Gravid adults were used to lay eggs onto fresh
NGMOP50 plates at 15 C. Eggswere raised at 15 C till L4 stage,
due to temperature sensitivity of mutant phenotypes. Once
this phase was reached, animals were transferred into a 25 C
environment. After 24 h at that temperature, 25 worms were
put onto each of 5 replicate NGM fresh plates containing the
extract or water as vehicle (control group). Animals were
transferred to fresh plates after 7 and 14 days and scored for
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used as for the juglone oxidative stressed assays (2.6.2). Re-
sults were represented as Survival Rate %.
2.6.4. Paralysis assay
C. elegans CL4176 is a transgenic strain which expresses
human b-amyloid peptide in muscle cells after up-shifting
temperature from 16 to 25 C, rapidly causing a paralysis.
CL4176 worms were egg-synchronized onto fresh NGM plates
with or without flower extract at appropriate concentrations.
When the animals grew to L3 larvae, the expression of human
Ab142 gene was induced by temperature upshifting from 15
to 25 C 24 h later, paralysis was scored at 2 h intervals until all
worms were paralyzed [17]. Worms were considered as para-
lyzed if there was no response or they only moved their head
when gently touched with a platinum wire. For each assay, at
least 100 nematodes were used per studied condition.
2.7. Statistical analysis
Three independent experiments were performed for the cited
assays. Statistical analysis was carried out using GraphPad
Prism version 6.0c for Mac OS X (GraphPad Software, San
Diego, CA, USA). Results were expressed as mean ± standard
errors mean (SEM). The 50% inhibitory concentration (IC50)
was estimated by means of a linear regression equation.
Comparisons and p value calculations were made between
treated and control animal using one-way ANOVA and
Tukey's multiple comparison test. The treatment effect on
lifespan and paralysis was determined using the Log-Rank
and Wilcoxon tests of fitting to the KaplaneMeier survival
model. Differences with p  0.05 were considered statistically
significant.3. Results and discussion
3.1. Phenolic compounds of V. cornuta and V. x
wittrockiana flower extracts
The obtained extracts had a yield of 4.83% and 5.65% (mass of
extract/mass of fresh flowers) for V. cornuta and V. x wit-
trockiana, respectively, and were analysed by LC-DAD-ESI/
MSn. Nine non-anthocyanin phenolic compounds were
found in V. cornuta, while ten and one anthocyanin compound
were detected in V. x wittrockiana (Table 1). Representative
chromatograms are shown in Fig. 1.
In consideration of the chromatographic characteristic
reported in Table 1, peaks 1e3, 7, 9, 10 were identified as
flavone glycoside derivatives (luteolin, apigenin, and chrysin
derivatives). All of the mentioned compounds presented a
fragmentation pattern characteristic of C-glycoside and were
all identified taking into account the hierarchical fragmenta-
tion pattern described by Ferreres et al. [18,19] thus peak 10
([MH] at m/z 577), was identified taking into account the
findings of Han et al. [20]. Moreover, compounds 7 and 9
([MH] at m/z 577) have been previously described in Viola
sp., being identified as apigenin-C-hexosyl-C-deoxyhexoside
(peak 7), apigenin-6-C-glucosyl-8-C-rhamnoside (violanthin,
peak 9) [5,6].Otherwise compounds 6, 11, 12 and 13 were positively
identified as myricetin-3-O-rutinoside quercetin-3-O-ruti-
noside (rutin), kaempferol-3-O-rutinoside, and iso-
rhamnetin-3-O-rutinoside respectively, by comparison with
authentic standards, as also by their MS fragmentation pat-
terns, retention times and UVevis characteristics. Rutin has
also been previously described in V. x wittrockiana by other
authors [5,6]. Compounds 4 ([MH] atm/z 771), 5 ([MH] at
m/z 755), and 8 ([MH] at m/z 739) were identified as myr-
icetin, quercetin and kaempferol derivatives owing to the
product ion observed atm/z 317, 301 and 285, respectively, as
also to their UV spectra (lmax around 347e356 nm). All the
peaks MS2 fragments revealed the alternative loss of a
deoxyhexosyl (146 u) and deoxyhexosyl-hexoside (308 u)
residues, indicating location of each residue on different
positions of the aglycone. Gonzalez-Barrio et al. detected a
similar compound to peak 5, being identified as quercetin-3-
O-(6-O-rhamnosylglucoside)-7-O-rhamnoside, thus this
assumption was taken into account for this compounds
identification [5]. For the remaining compounds (peak 4 and
8), similar reasoning's were also considered, being these
peaks identified as myricetin-3-O-(6-O-rhamnosylgluco-
side)-7-O-rhamnoside and kaempferol-3-O-(6-O-rhamnosyl-
glucoside)-7-O-rhamnoside, respectively.
Peak 14 ([MH] atm/z 625) indicated that it corresponds to
an anthocyanin derivative, such as a peonidin derivative,
owing to the product ion observed atm/z 317. The observation
of MS2 fragments at m/z 479 (146 u) and 317 (162 u), indi-
cated the alternative loss of each of the deoxyhexosyl and
hexosyl moieties, respectively, pointing to their location on
different positions of the aglycone, thus being identified as
petunidin-O-deoxyhexoside-hexoside. This compound was
only found in the flower extract of V. x wittrockiana and, to the
authors knowledge, has not been previously reported.
For V. cornuta, the three major components, ordered from
the highest to the lowest concentration, were identified as
quercetin-3-O-rutinoside (peak 11), chrysin-6,8-di-C-glucoside
(peak 10) and quercetin-3-O-(6-O-rhamnosylglucoside)-7-O-
rhamnoside (peak 5), respectively; whereas for V. x wit-
trockiana extract, the major components were quercetin-3-O-
(6-O-rhamnosylglucoside)-7-O-rhamnoside (peak 5), myr-
icetin-3-O-(6-O-rhamnosylglucoside)-7-O-rhamnoside (peak
4), and quercetin-3-O-rutinoside (peak 11). Other flavonoid
glycosides derivatives were present in minor proportions,
such as luteolin, apigenin, kaempferol, and isorhamnetin
derivatives.
Anthocyanins compounds were not found in V. cornuta. As
far as we know, the only research about its chemical compo-
sitionwas published by Farzad, Griesbach,&Weiss, (2002) [21],
who studied V. cornuta (var. Yesterday Today and Tomorrow),
which changed its colour from white to purple over 5e8 days.
This work shows an increasing composition of anthocyani-
dins during colour change phases, a lack of them when petals
were white and a maximum concentration when petals
develop a purple colour. This is in concordance with the
absence of anthocyanins in the extract, because their pres-
ence is related to violet and purple petal colours, being the
sample studied of yellow petals. On the other hand, the
polyphenol content of V. x wittrockiana flowers was higher
than that described by Gonzalez-Barrio et al. but the
Table 1 e Retention time (Rt), wavelengths of maximum absorption in the visible region (lmax), mass spectral data and tentative identification of the phenolic compounds
present in V. cornuta and V. x wittrockiana.
Peak Rt (min) lmax (nm) Molecular
ion [MH]
(m/z)
MS2 (m/z) Tentative identification Reference Quantification t-Students
test p-valueV. cornuta V. x wittrockiana
Non-anthocyanin phenolic compounds
1 6.82 263,294,348 609 519(24),489(100),
447(54),357(6),327(20)
Luteolin-O-hexoside-C-hexosideA [19] 1.23 ± 0.04 nd e
2 7.30 265,293,347 609 489(100),399(6),369(5) Luteolin-6,8-di-C-glucosideA [32] nd 0.78 ± 0.001 e
3 9.77 334 593 503(29),473(100),
383(12),353(20),325(2)
Apigenin-6,8-di-C-glucosideA [32] 0.58 ± 0.01 2.40 ± 0.03 <0.001
4 11.79 356 771 625(20),317(100) Myricetin-3-O-(6-O-
rhamnosylglucoside)-7-O-
rhamnosideB
DAD, ESI/MS nd 10.3 ± 0.2 e
5 14.31 355 755 609(32),301(100) Quercetin-3-O-(6-O-
rhamnosylglucoside)-7-O-
rhamnosideB
[5] 1.27 ± 0.01 29.1 ± 0.4 <0.001
6 15.03 350 625 317 (100) Myricetin-3-O-rutinosideB Standard nd 3.8 ± 0.1 e
7 15.44 336 577 473(100),457(28),
413(20),311(3)
Apigenin-C-hexosyl-C-
deoxyhexosideA
[18] 0.53 ± 0.01 nd e
8 16.41 347 739 593(21),285(100) Kaempferol-3-O-(6-O-
rhamnosylglucoside)-7-O-
rhamnosideB
DAD, ESI/MS nd 1.26 ± 0.001 e
9 16.59 334 577 473(100),457(30),
413(10),353(30),295(2)
Apigenin-6-C-glucosyl-8-C-
rhamnoside (violanthin)A
[5,6] 1.05 ± 0.03 nd e
10 16.91 268,335sh 577 559(18),517(5),
487(49),457(100),
413(6),311(5)
Chrysin-6,8-di-C-glucosideA [20] 6.52 ± 0.04 4.80 ± 0.04 <0.001
11 17.61 355 609 609 (100) Quercetin-3-O-rutinosideB Standard [5,6]; 7.5 ± 0.1 10.1 ± 0.3 <0.001
12 20.99 263,346 593 285 (100) Kaempferol-3-O-rutinosideB Standard 0.71 ± 0.01 0.75 ± 0.01 <0.001
13 22.93 354 623 315 (100) Isorhamnetin-3-O-rutinosideB Standard 0.59 ± 0.01 0.75 ± 0.02 <0.001
Total non-anthocyanin phenolic
compounds
e 19.9 ± 0.01 64 ± 1 <0.001
Peak Rt (min) lmax (nm) Molecular ion
[M þ H]þ (m/z)
MS2 (m/z) Tentative identification Reference V. cornuta V. x wittrockiana t-Students test p-value
Anthocyanin phenolic compounds
14 33.48 530 625 479(20),317(100) Petunidin-O-deoxyhexoside-
hexosideC
DAD, ESI/MS nd 5.05 ± 0.04 e
nd-not detected. Standard calibration curves: A - apigenin-6-C-glucoside (y ¼ 107025x þ 61,531, R2¼ 0.9989); B - quercetin-3-O-glucoside (y ¼ 34843x e 160,173, R2 ¼ 0.9998); C - peonidin-3-O-glucoside
(y ¼ 166905x e 442,698, R2 ¼ 0.9993).
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Fig. 1 e Phenolic profile of V. cornuta recorded at 370 nm (A), and V. x wittrockiana recorded at 370 nm (B) and 520 nm (C).
Numbers 1 to 14 refers to peaks from Table 1.
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reported flavonols as the main compounds, such as quercetin
and myricetin, which were also the major phenolic com-
pounds in the present study. Additionally, V. x wittrockiana
flowers also showed a higher concentration of flavonoid when
compared to the ones previously reported by Vukics et al. in
violet V. x wittrockiana flowers [6]. The differences could be
related to the type of extraction, as well as the origin and
period of flower harvesting.
The high polyphenol content of both extracts suggests that
the flowers of both species can be an interesting source of
antioxidants and bioactive molecules.
3.2. In vitro cell-free antioxidant activity assays (TPC,
DPPH· assay, FRAP)
Three different antioxidant methods were used to evaluate
the reducing capacity for both flower extracts (results given in
Table 2). Firstly, TPC was determined in comparison to pyro-
gallol standard, being significantly higher on V. x wittrockiana
(p 0.001) than in V. cornuta, withmean values of 80.18 ± 0.007
and 54.92 ± 0.008 mg PE/g extract, respectively. These values
differ from those obtained through the chromatographic
analysis of phenolic compounds, being that the quantity in
both species were overestimated. The difference could be
attribute to the presence of other non-phenolic reducing
compounds that can react with the Folin- Ciocalteu reagent,
such as proteins, thiols or vitamins [22]. Due to non-
specificity, TPC is currently used as a parameter of
antioxidant-reducing activity. Our results of V. x wittrockiana
are higher than those from the study by Gonzalez-Barrio et al.
who reported a TPC of 44.88 ± 1.43 mg GAE/g dry weight of
extract obtained by maceration [5].
The free radical scavenging activity was determined by the
DPPH· assay. As observed in Table 2, both studied ethanolic
extracts inhibited around 85% of the DPPH· radicals at the
maximum dose tested (250 mg/mL). The extract of V. x wit-
trockiana flowers showed a higher DPPH· radical-scavenging
activity (IC50, 26.1 ± 0.8 mg/mL) in comparison to V. cornuta
extract (IC50, 39 ± 2 mg/mL) and significant differences were
found between them (p  0.01). Similar DPPH inhibition was
found by Gonzalez-Barrio et al. in a V. x wittrockiana flower
extract obtained by maceration (71.20%) [5]. Besides, our re-
sults seem to be better to the data obtained forV. x wittrockiana
carried out by Fernandes et al. [23,24].
The FRAP assay estimates the antioxidant activity related
to the capacity of the samples to reduce Fe3þ-TPTZ to Fe2þ-Table 2 e Antioxidant and enzyme inhibition activity of flowe
independent replicates. Control substances were used in the a
clorgyline for MAO-A).
TPC mg PE/g extract DPPH$ IC50
mg/mL
V. cornuta 54.92 ± 0.008 39 ± 2
V. wittrokiana 80.18 ± 0.007 26.1 ± 0.8
t-Students test p-value 0.001 0.01
Control substance e 3.17 ± 0.03
ND, no detected activity. p-values were calculated to compared differencTPTZ. Lower FRAP values were found for V. cornuta 24 ± 2 mmol
Feþ2/g extract, while Viola wittrokiana revealed a slightly
higher value 35 ± 2 mmol Feþ2/g extract (p  0.05). As far as we
know, there is no previous data of reducing power for V. cor-
nuta, however, for yellow flowers of V. x wittrockiana the re-
ported value was 33.1 mmol Feþ2/g fresh weigh basis [4] and
2063.7 mmol Feþ2/g dry weight of sample [5]. Comparison is
difficult due to the fact that results are expressed in relation to
the mass of the dry plant material instead of the extracts.
The measurement of free radical scavenging activity and
iron ion reduction ability shows a potent antioxidant effect in
both species. This activity could be related to the presence of
polyphenols.
3.3. Enzyme inhibition bioassays
The in vitro neuroprotective potential was measured through
the MAO-A and AChE inhibitory activity, which are connected
with neurodegenerative disorders like Alzheimer's and Par-
kinson's diseases. Results are summarized in Table 2. Inter-
estingly, V. x wittrockiana extract showed inhibitory activity
against both enzymes, while V. cornuta extract did not show
any activity. Flower extract of V. x wittrockiana inhibited MAO
A with a IC50 value of 0.3 ± 0.1 mg/mL. This inhibition could be
due to quercetin and related flavonoids [25]. On the other
hand, the IC50 value for AChE was 1.5 ± 0.1 mg/mL. This ac-
tivity may also be due to the higher proportions of quercetin
derivatives, which also have shown potential AChE inhibitory
effect [26]. Thus, this is the first time the V. x wittrockiana has
shown potential to inhibit CNS enzymes.
3.4. Flower extracts increases survival of C. elegans
under lethal oxidative stress
For the oxidative resistance assays, nematodes were pre-
treated with different doses of flower extracts and then
exposed to juglone, a pro-oxidant agent. Both extracts reduced
the toxicity of juglone increasing the survival ratewith respect
to the control group (Fig. 2). The best response to oxidative
stress were found in the group treated with 100 mg/mL,
showing an increase of 6.8% survival rate for V. cornuta
(p  0.001) and 10.75% for V. x wittrokiana (p  0.01) with
regards to the control group. For V. cornuta, all tested doses
showed a significant increase of survival. On the other hand,
the treatment with V. x wittrockiana had a noteworthy effect
on survival rate at concentrations of 250 and 100 mg/mL
(p 0.05). Our results report a better protective potential for V.r extracts. Results are represented as mean ± SEM of three
ssays (ascorbic acid for DPPH·, galantamine for AChE and
FRAP
mmol
Fe2þ/g extract
AChE
IC50 mg/mL
MAO A
IC50 mg/mL
25 ± 2 ND ND
35 ± 2 1.5 ± 0.1 0.3 ± 0.1
0.05 e e
e 6.3  104 ± 0.02 4.9  104 ± 0.01
es between the two extracts.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 7 ( 2 0 1 9 ) 8 4 9e8 5 9856x wittrokiana than for V. cornuta, which is in accordance with
the phenolic content and the in vitro antioxidant activity pre-
viously described.
Other authors have demonstrated that compounds pre-
sent in the extracts have revealed a protective effect
against oxidative stress on C. elegans. Surco-Laos et al. re-
ported an increased survival rate in worms pre-treated
with quercetin exposed to juglone-induced oxidative
stress [15], also myricetin treatment reduced oxidative
damage of biomolecules [27].
3.5. V. cornuta flower extract extends the lifespan of C.
elegans
C. elegans is a widespread model to study aging because of its
short lifespan and well conserved key mechanism of ageing
[7]. As illustrated in Fig. 3, V. x wittrockiana showed no impact
on lifespan extension, but at the highest dose tested (250 mg/
mL) had a negative effect in the survival curve compared with
control (p < 0.01). According to previousworks, higher doses of
quercetin, which is the major compound found in the testedFig. 2 e Effects of (A) V. cornuta and (B) V. x wittrockiana
extracts on the response to a lethal oxidative stress
induced by juglone (150 mM) on C. elegans. Three
independent biological replicates were performed.
Differences compared to control group were considered
significant at p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***).extract, shorten worm lifespan being in vivo pro-oxidant and
toxic effects responsible for this fact [28].
In the case of V. cornuta, all concentrations had a positive
effect on lifespan, significant differences were found in the
survival curves of the treatments with the control group
(p  0.05). The present study does not allow us to conclude
which mechanisms are involved in lifespan lengthening, but
similar experiments were carried out with the majority of
phytochemicals present in this extract such as quercetin and
chrysin. The life-extending effect in wild type C. elegans
exposed to 30 mg/mL of quercetin was observed by Gru¨nz et al.,
who then repeated the assay using strain TK22, which has a
hypersensitivity to oxidative stress, to assess if it was related
to antioxidant properties, thus no effect in lifespan was found
[27]. However, quercetin reduced mitochondrial ROS levels of
nematodes. Furthermore, chrysin also increased lifespan
maybe due to AMPK activation [29].
3.6. Neuroprotective effects of V. x wittrockiana extract
in C. elegans
In order to determine the protective effect of the edible
flowers against b-amyloid toxicity, C. elegans CL4176 were
exposed to different concentrations of extracts, fromegg stage
until paralysis. The time to develop paralysis was analysed
using survival curves. As shown in Fig. 4, paralysis was
delayed with both extracts; apparently, treatments with V. x
wittrockiana were better than with V. cornuta. The paralysis
time for 50% of nematodes (PT50) was not different between
treatment groups of V. cornuta and control with a value of 28 h,
but all treatment concentrations caused a significant
increased lifespan (p < 0.01). On the other hand, V. x wit-
trockiana extract delayed the onset of paralysis in a
doseeresponse manner. Compared to the control group, V. x
wittrockiana extract at 50 mg/mL showed the same value of PT50
which correspond to 44 h, however, this value was delayed up
to 9.09% and 54.44% at 100 and 250 mg/mL, respectively, for
treated groups (p < 0.001).
Experimental and clinical evidence suggest that oxidative
stress plays a crucial role in the pathogenesis of Alzheimer
disease. This phenomenon also occurs in C. elegans CL4176,
where oxidative stress precedes to b-amyloid accumulation
[17]. The antioxidant potential observed in vitro as well as the
improvement in response to lethal oxidative stress in C.
elegans can explain the protective effect of V. cornuta extract
in this neurodegenerative model. The results obtained from
V. x wittrockiana possibly due to a synergy of inhibitory
enzymatic and antioxidant activity, as well as the poly-
phenol content of the extract. The neuroprotective effects of
the main polyphenols have never been evaluated in this
model.
It is important to highlight that, in this nematode, there are
key enzymes related to neurotransmittermetabolism, such as
AChE and MAO [30], being acetylcholinesterase inhibitors one
of the cornerstones of Alzheimer disease treatment. Flavo-
noids extracted from plants, such as quercetin, have been
reported to possess an outstanding preclinical efficacy as
AChE inhibitors with potential to be candidates for clinical
applications such as treating Alzheimer's disease and other
cholinergic dysfunctions [31].
Fig. 3 e Effects of (A) V. cornuta and (B) V. x wittrockiana extracts on lifespan of C. elegans SS104. Three replicates were used
per treatment. The mean lifespan was 14 days in all groups, except in nematodes treated with 100 mg/mL was 12 days.
Results of lifespan experiments were analysed using KaplaneMeier survival model and for significance by means of a long
rank pairwise comparison test between the control and treatment groups. Differences in survival curves between treatment
and control groups were found in:(A) 25 *, 50 ***, and 250** mg/mL; (B): 250 (**) mg/mL. Differences compared to control group
were considered significant at p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***).
j o u r n a l o f f o o d and d ru g an a l y s i s 2 7 ( 2 0 1 9 ) 8 4 9e8 5 9 857
Fig. 4 e Effect of (A) V. cornuta and (B) V. x wittrockiana extracts on Ab-induced paralysis in transgenic C. elegans CL4176. Three
replicates were examined per treatment. Statistical significance difference between the curves was analysed by log-rank
(KaplaneMeier) statistical testwhich compares the survival distributionsbetween the control and treatment groups.Differences
insurvival curvesbetweentreatmentandcontrol groupswere found in:(A)50 **, 100*** and250*mg/mL; (B): 50, 100and250 (***)mg/
mL. Differences compared to control group were considered significant at p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***).
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 7 ( 2 0 1 9 ) 8 4 9e8 5 98584. Conclusion
To summarize, our study reveals that both edible flowers, V.
cornuta and V. x wittrokiana, are a good source of phenolic
compounds. These two flowers have demonstrated in vitro
and in vivo antioxidant activity but V. x wittrockiana shows
higher levels of phenolic compounds and bioactivity. More-
over, the potential of these extracts as agents to prevent
certain CNS diseases has been mainly established for V. x
wittrokiana.Conflicts of interest
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